Biopharmaceutical CMO CRO Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Contract Manufacturing
1.3.3 Contract Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2017-2028)
2.2 Biopharmaceutical CMO & CRO Growth Trends by Region
2.2.1 Biopharmaceutical CMO & CRO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical CMO & CRO Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical CMO & CRO Market Dynamics
2.3.1 Biopharmaceutical CMO & CRO Industry Trends
2.3.2 Biopharmaceutical CMO & CRO Market Drivers
2.3.3 Biopharmaceutical CMO & CRO Market Challenges
2.3.4 Biopharmaceutical CMO & CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
3.4 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2021
3.5 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO & CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO & CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical CMO & CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical CMO & CRO Market Size (2017-2028)
6.2 North America Biopharmaceutical CMO & CRO Market Size by Type
6.2.1 North America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
6.2.2 North America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
6.2.3 North America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
6.3 North America Biopharmaceutical CMO & CRO Market Size by Application
6.3.1 North America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
6.3.2 North America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
6.3.3 North America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
6.4 North America Biopharmaceutical CMO & CRO Market Size by Country
6.4.1 North America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
6.4.2 North America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO & CRO Market Size (2017-2028)
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type
7.2.1 Europe Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
7.2.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
7.2.3 Europe Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application
7.3.1 Europe Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
7.3.2 Europe Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
7.3.3 Europe Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
7.4 Europe Biopharmaceutical CMO & CRO Market Size by Country
7.4.1 Europe Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
7.4.2 Europe Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO & CRO Market Size (2017-2028)
9.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
9.2.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
9.2.3 Latin America Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
9.3 Latin America Biopharmaceutical CMO & CRO Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
9.3.2 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
9.3.3 Latin America Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
9.4 Latin America Biopharmaceutical CMO & CRO Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
9.4.2 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type (2017-2028)
10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.2.5 Boehringer Ingelheim GmbH Recent Developments
11.3 Rentschler Biotechnologie GmbH
11.3.1 Rentschler Biotechnologie GmbH Company Details
11.3.2 Rentschler Biotechnologie GmbH Business Overview
11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
11.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.3.5 Rentschler Biotechnologie GmbH Recent Developments
11.4 Inno Biologics Sdn Bhd
11.4.1 Inno Biologics Sdn Bhd Company Details
11.4.2 Inno Biologics Sdn Bhd Business Overview
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
11.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.4.5 Inno Biologics Sdn Bhd Recent Developments
11.5 JRS Pharma (Celonic GmbH)
11.5.1 JRS Pharma (Celonic GmbH) Company Details
11.5.2 JRS Pharma (Celonic GmbH) Business Overview
11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Introduction
11.5.4 JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.5.5 JRS Pharma (Celonic GmbH) Recent Developments
11.6 BIOMEVA GmbH
11.6.1 BIOMEVA GmbH Company Details
11.6.2 BIOMEVA GmbH Business Overview
11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
11.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.6.5 BIOMEVA GmbH Recent Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Details
11.7.2 ProBioGen Business Overview
11.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
11.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.7.5 ProBioGen Recent Developments
11.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
11.9 TOYOBO CO., LTD
11.9.1 TOYOBO CO., LTD Company Details
11.9.2 TOYOBO CO., LTD Business Overview
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
11.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.9.5 TOYOBO CO., LTD Recent Developments
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.10.5 Samsung BioLogics Recent Developments
11.11 Patheon
11.11.1 Patheon Company Details
11.11.2 Patheon Business Overview
11.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
11.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.11.5 Patheon Recent Developments
11.12 CMC Biologics
11.12.1 CMC Biologics Company Details
11.12.2 CMC Biologics Business Overview
11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
11.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.12.5 CMC Biologics Recent Developments
11.13 Binex Co., Ltd.
11.13.1 Binex Co., Ltd. Company Details
11.13.2 Binex Co., Ltd. Business Overview
11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
11.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.13.5 Binex Co., Ltd. Recent Developments
11.14 AbbVie Inc.
11.14.1 AbbVie Inc. Company Details
11.14.2 AbbVie Inc. Business Overview
11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
11.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.14.5 AbbVie Inc. Recent Developments
11.15 WuXi Biologics.
11.15.1 WuXi Biologics. Company Details
11.15.2 WuXi Biologics. Business Overview
11.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Introduction
11.15.4 WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022)
11.15.5 WuXi Biologics. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biologics
Table 3. Key Players of Biosimilars
Table 4. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Biopharmaceutical CMO & CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biopharmaceutical CMO & CRO Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Biopharmaceutical CMO & CRO Market Share by Region (2017-2022)
Table 8. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Biopharmaceutical CMO & CRO Market Share by Region (2023-2028)
Table 10. Biopharmaceutical CMO & CRO Market Trends
Table 11. Biopharmaceutical CMO & CRO Market Drivers
Table 12. Biopharmaceutical CMO & CRO Market Challenges
Table 13. Biopharmaceutical CMO & CRO Market Restraints
Table 14. Global Biopharmaceutical CMO & CRO Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Biopharmaceutical CMO & CRO Revenue Share by Players (2017-2022)
Table 16. Global Top Biopharmaceutical CMO & CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2021)
Table 17. Ranking of Global Top Biopharmaceutical CMO & CRO Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO & CRO Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biopharmaceutical CMO & CRO Product Solution and Service
Table 21. Date of Enter into Biopharmaceutical CMO & CRO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2017-2022)
Table 25. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2023-2028)
Table 27. Global Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Biopharmaceutical CMO & CRO Revenue Share by Application (2017-2022)
Table 29. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Biopharmaceutical CMO & CRO Revenue Share by Application (2023-2028)
Table 31. North America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Biopharmaceutical CMO & CRO Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Biopharmaceutical CMO & CRO Market Size by Country (2023-2028) & (US$ Million)
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Biopharmaceutical CMO & CRO Product
Table 64. Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 65. Lonza Recent Developments
Table 66. Boehringer Ingelheim GmbH Company Details
Table 67. Boehringer Ingelheim GmbH Business Overview
Table 68. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product
Table 69. Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 70. Boehringer Ingelheim GmbH Recent Developments
Table 71. Rentschler Biotechnologie GmbH Company Details
Table 72. Rentschler Biotechnologie GmbH Business Overview
Table 73. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product
Table 74. Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 75. Rentschler Biotechnologie GmbH Recent Developments
Table 76. Inno Biologics Sdn Bhd Company Details
Table 77. Inno Biologics Sdn Bhd Business Overview
Table 78. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product
Table 79. Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 80. Inno Biologics Sdn Bhd Recent Developments
Table 81. JRS Pharma (Celonic GmbH) Company Details
Table 82. JRS Pharma (Celonic GmbH) Business Overview
Table 83. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product
Table 84. JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 85. JRS Pharma (Celonic GmbH) Recent Developments
Table 86. BIOMEVA GmbH Company Details
Table 87. BIOMEVA GmbH Business Overview
Table 88. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product
Table 89. BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 90. BIOMEVA GmbH Recent Developments
Table 91. ProBioGen Company Details
Table 92. ProBioGen Business Overview
Table 93. ProBioGen Biopharmaceutical CMO & CRO Product
Table 94. ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 95. ProBioGen Recent Developments
Table 96. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
Table 97. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Product
Table 99. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 100. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
Table 101. TOYOBO CO., LTD Company Details
Table 102. TOYOBO CO., LTD Business Overview
Table 103. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product
Table 104. TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 105. TOYOBO CO., LTD Recent Developments
Table 106. Samsung BioLogics Company Details
Table 107. Samsung BioLogics Business Overview
Table 108. Samsung BioLogics Biopharmaceutical CMO & CRO Product
Table 109. Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 110. Samsung BioLogics Recent Developments
Table 111. Patheon Company Details
Table 112. Patheon Business Overview
Table 113. Patheon Biopharmaceutical CMO & CRO Product
Table 114. Patheon Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 115. Patheon Recent Developments
Table 116. CMC Biologics Company Details
Table 117. CMC Biologics Business Overview
Table 118. CMC Biologics Biopharmaceutical CMO & CRO Product
Table 119. CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 120. CMC Biologics Recent Developments
Table 121. Binex Co., Ltd. Company Details
Table 122. Binex Co., Ltd. Business Overview
Table 123. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product
Table 124. Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 125. Binex Co., Ltd. Recent Developments
Table 126. AbbVie Inc. Company Details
Table 127. AbbVie Inc. Business Overview
Table 128. AbbVie Inc. Biopharmaceutical CMO & CRO Product
Table 129. AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 130. AbbVie Inc. Recent Developments
Table 131. WuXi Biologics. Company Details
Table 132. WuXi Biologics. Business Overview
Table 133. WuXi Biologics. Biopharmaceutical CMO & CRO Product
Table 134. WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2017-2022) & (US$ Million)
Table 135. WuXi Biologics. Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO & CRO Market Share by Type: 2021 VS 2028
Figure 2. Biologics Features
Figure 3. Biosimilars Features
Figure 4. Global Biopharmaceutical CMO & CRO Market Share by Application: 2021 VS 2028
Figure 5. Contract Manufacturing Case Studies
Figure 6. Contract Research Case Studies
Figure 7. Biopharmaceutical CMO & CRO Report Years Considered
Figure 8. Global Biopharmaceutical CMO & CRO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Biopharmaceutical CMO & CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Biopharmaceutical CMO & CRO Market Share by Region: 2021 VS 2028
Figure 11. Global Biopharmaceutical CMO & CRO Market Share by Players in 2021
Figure 12. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO & CRO as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO & CRO Revenue in 2021
Figure 14. North America Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
Figure 16. North America Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
Figure 17. North America Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
Figure 18. United States Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
Figure 22. Europe Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
Figure 23. Europe Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
Figure 24. Germany Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Biopharmaceutical CMO & CRO Market Size Share by Region (2017-2028)
Figure 34. China Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
Figure 44. Mexico Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Biopharmaceutical CMO & CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Biopharmaceutical CMO & CRO Market Size Share by Country (2017-2028)
Figure 50. Turkey Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Biopharmaceutical CMO & CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Lonza Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 54. Boehringer Ingelheim GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 55. Rentschler Biotechnologie GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 56. Inno Biologics Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 57. JRS Pharma (Celonic GmbH) Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 58. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 59. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 61. TOYOBO CO., LTD Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 62. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 63. Patheon Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 64. CMC Biologics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 65. Binex Co., Ltd. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 66. AbbVie Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 67. WuXi Biologics. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed